Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process
about
Identification and Characterization of Dpo42, a Novel Depolymerase Derived from the Escherichia coli Phage vB_EcoM_ECOO78.Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice.Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue.Hydrolytic activity determination of Tail Tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates.The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence.Comparative Analysis of 37 Acinetobacter Bacteriophages.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.Characterization of a newly isolated phage infecting pathogenic Escherichia coli and analysis of its mosaic structural genes.Phage-Borne Depolymerases Decrease Resistance to Innate Defense MechanismsBacteriophage Sf6 Tailspike Protein for Detection of PathogensMycobacteriophage Lysis Enzymes: Targeting the Mycobacterial Cell EnvelopeTherapeutic Application of Bacteriophage PHB02 and Its Putative Depolymerase Against Capsular Type A in MiceAntibacterial Activity of a Lytic Enzyme Encoded by Double Stranded RNA Bacteriophage phiYY
P2860
Q40086431-C98EEE8D-82A5-4161-921B-903BDF913353Q46230519-35B440BF-6C1B-42C1-B6BF-282CF3905181Q47104261-66820982-9C6B-48CC-9542-E4C3F6239671Q47120147-8F9FB08C-188C-4E20-96D9-7AA178689D65Q47130097-8B2D3294-6E24-4D5C-8B3B-660A63198ABEQ47237426-888D2AE0-701C-4261-BEE5-0EB94ED7C325Q50016951-50AF9258-2598-420C-AE62-0C1923E12D6CQ52315864-BAFA97A2-3309-4469-ADD5-3C439F927346Q52642775-D8BE7E43-F9D6-4BB4-BEB9-1B471168D969Q55212571-DB7D5979-7047-4201-BE5E-8145EC846520Q58572887-0CC5748C-9E6F-4396-A8EA-3C90D9A460F7Q58776733-B7B8E08A-134F-40CE-A478-6FDE9197391BQ58780325-0D134A7D-7554-43DA-9D86-086A900EAA17Q58797273-A3F7D782-5950-4652-A9E6-A8815945709EQ58801468-099317C6-DADC-4F3C-83C0-A72213EBD28D
P2860
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bacteriophage-encoded virion-a ...... s during the infection process
@en
Bacteriophage-encoded virion-a ...... during the infection process.
@nl
type
label
Bacteriophage-encoded virion-a ...... s during the infection process
@en
Bacteriophage-encoded virion-a ...... during the infection process.
@nl
prefLabel
Bacteriophage-encoded virion-a ...... s during the infection process
@en
Bacteriophage-encoded virion-a ...... during the infection process.
@nl
P2093
P2860
P921
P1476
Bacteriophage-encoded virion-a ...... s during the infection process
@en
P2093
Barbara Maciejewska
Grazyna Majkowska-Skrobek
Yves Briers
P2860
P2888
P304
P356
10.1007/S00253-017-8224-6
P407
P5008
P577
2017-03-23T00:00:00Z
2017-04-01T00:00:00Z